• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Recent Advances in the Study of Methyl(4,6-dichloro-2-methylpyrimidin-5-yl)acetate (CAS: 142228-52-2)

Methyl(4,6-dichloro-2-methylpyrimidin-5-yl)acetate (CAS: 142228-52-2) is a key intermediate in the synthesis of various biologically active compounds, particularly in the pharmaceutical and agrochemical industries. Recent studies have highlighted its significance in the development of novel therapeutic agents and its role in chemical synthesis. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its applications, synthesis methods, and biological activities.

One of the most notable advancements in the study of Methyl(4,6-dichloro-2-methylpyrimidin-5-yl)acetate is its application in the synthesis of pyrimidine-based drugs. Pyrimidine derivatives are known for their diverse pharmacological properties, including antiviral, anticancer, and anti-inflammatory activities. Recent research has demonstrated that this compound serves as a versatile building block for the development of such derivatives, enabling the creation of more potent and selective therapeutic agents.

In terms of synthesis, recent studies have explored more efficient and environmentally friendly methods for producing Methyl(4,6-dichloro-2-methylpyrimidin-5-yl)acetate. Traditional synthetic routes often involve harsh conditions and generate significant waste. However, newer approaches, such as catalytic methods and green chemistry techniques, have shown promise in improving yield and reducing environmental impact. These advancements are particularly relevant given the increasing emphasis on sustainable practices in chemical manufacturing.

Biological studies have also shed light on the potential mechanisms of action of compounds derived from Methyl(4,6-dichloro-2-methylpyrimidin-5-yl)acetate. For instance, some derivatives have been found to inhibit specific enzymes involved in disease pathways, offering new targets for drug development. Additionally, structure-activity relationship (SAR) studies have provided valuable insights into how modifications to the pyrimidine core can enhance biological activity and reduce toxicity.

Despite these promising developments, challenges remain in the widespread application of Methyl(4,6-dichloro-2-methylpyrimidin-5-yl)acetate. Issues such as scalability, cost-effectiveness, and regulatory approval need to be addressed to fully realize its potential. Future research directions may include further optimization of synthetic routes, expanded biological testing, and exploration of new applications in drug discovery and beyond.

In conclusion, Methyl(4,6-dichloro-2-methylpyrimidin-5-yl)acetate continues to be a compound of significant interest in the field of chemical biology and medicinal chemistry. Its versatility as a synthetic intermediate and its potential in drug development make it a valuable focus for ongoing research. By addressing current challenges and leveraging recent advancements, researchers can unlock new opportunities for innovation in this area.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)